N1-Headache™ offers a digital platform for managing migraine by monitoring headache outcomes and identifying risk factors. It connects patients with healthcare providers through a mobile app and web-based dashboard.

Curelator Inc.

N1-Headache™

Curelator Inc. | 2,636 followers on LinkedIn. The Digital Health Platform to practice personalized, evidence-based medicine | Founded in Cambridge, Massachusetts, in 2013, Curelator develops clinical grade, personalized disease management tools for patients and clinicians. Currently, its main platform is N1-Headache™, a unique patient engagement platform that delivers individualized, disease management tools for people with a history of migraine, allowing them to understand their migraine attack patterns, and what may affect these,  in an individualized manner. 

Since its inception, Curelator has published dozens of papers and abstracts in major headache and migraine journals and at medical conferences.

N1-H

COM:N1-HEADACHE

N1-Headache™

name

homepage url

country

linkedin url

crunchbase url

sector

industry

monthly webtraffic

Description

competitor of

Metrics